EVH · Evolent Health, Inc. · Webcasts, Transcripts & Audio
$3.60
+0.14 (+3.90%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$408.14M
Shares
113.06M
Volume · Oct 5
672.24K
Avg daily vol (3M)
2.99M
Evolent Health, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Evolent Health, Inc. (EVH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲58.5%
$352.58M
$2.12M
'22 Q3
22-11-02
▲54%
$382.43M
−$11.35M
'22 Q4
23-02-22
▲44%
$427.69M
−$19.98M
'23 Q1
23-05-03
▲46.6%
$469.14M
−$34.32M
'23 Q2
23-08-02
▲44.9%
$511.01M
−$25.32M
'23 Q3
23-11-02
▲45.4%
$556.05M
−$33.41M
'23 Q4
24-02-22
▲49.6%
$639.65M
−$17.28M
'24 Q1
24-05-09
▲37.9%
$647.14M
$1.60M
'24 Q2
24-08-08
▲21.6%
$621.40M
−$23.14M
'24 Q3
24-11-07
▲16.3%
$646.54M
−$22.80M
'24 Q4
25-02-20
▼24.4%
$483.65M
−$64.62M
'25 Q1
25-05-08
▼31.3%
$444.33M
−$19.90M
'25 Q2
25-08-07
▼22.8%
$479.53M
−$20.86M
'25 Q3
25-11-06
▼27.5%
$468.72M
−$429.13M
'25 Q4
26-02-24
▲2.6%
$496.25M
−$26.63M
'26 Q1
26-05-07
LATEST
▲46.9%
$652.52M
−$28.36M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Evolent Health, Inc. (EVH) Q2 2026 Earnings Call Transcript
Confident tone
Performance Suite launches and growth
2027 Medicaid and exchange headwinds
Medical Expense Ratio and reserving
Revenue
$652.52M
▲ 46.9% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
Positive tone
Performance Suite and new client launches
Oncology and medical cost trend
Financial guidance and outlook
Revenue
$496.25M
▲ 2.6% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript
Positive tone
Performance Suite contract migration
2026 revenue and EBITDA guidance
New partnerships and customer wins
Revenue
$468.72M
▼ 27.5% YoY Diluted EPS
$-3.84
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript
Confident tone
Oncology market opportunity and pipeline
Performance Suite and enhanced protections
Margin expansion and adjusted EBITDA
Revenue
$479.53M
▼ 22.8% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Evolent Health, Inc. (EVH) Q2 2025 Earnings Call Transcript
Positive tone
Oncology trend and Performance Suite
New partner wins and pipeline
2026 outlook
Revenue
$444.33M
▼ 31.3% YoY Diluted EPS
$-0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Evolent Health, Inc. (EVH) Q1 2025 Earnings Call Transcript
Revenue
$483.65M
▼ 24.4% YoY Diluted EPS
$-0.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript
Positive tone
Oncology cost trend and Performance Suite profitability
Organic growth and new contracts
2025 financial outlook and guidance
Revenue
$646.54M
▲ 16.3% YoY Diluted EPS
$-0.27
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Evolent Health, Inc. (EVH) Q3 2024 Earnings Call Transcript
Cautious tone
Reimbursement rate renegotiation
Specialty performance suite underwriting losses
2024 guidance reset / lowered EBITDA outlook
Revenue
$621.40M
▲ 21.6% YoY Diluted EPS
$-0.27
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
Positive tone
2024 Adjusted EBITDA Guidance and $300M Exit Run Rate Target
New Revenue Agreements / Bookings
Rate Increases from Performance Suite Partners
Revenue
$647.14M
▲ 37.9% YoY Diluted EPS
$-0.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Evolent Health, Inc. (EVH) Q1 2024 Earnings Call Transcript
Positive tone
Revenue growth and guidance raise
Profitability and EBITDA expansion
Utilization and risk business pressures
Revenue
$639.65M
▲ 49.6% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript
Confident tone
Financial Results and 2024 Outlook
Specialty Care / Performance Suite Expansion
Oncology and Technology and Services Suite
Revenue
$556.05M
▲ 45.4% YoY Diluted EPS
$-0.36
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript
Revenue
$511.01M
▲ 44.9% YoY Diluted EPS
$-0.30
▼ 1600% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Evolent Health, Inc. (EVH) Q2 2023 Earnings Call Transcript
Revenue
$469.14M
▲ 46.6% YoY Diluted EPS
$-0.37
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript
Revenue
$427.69M
▲ 44% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Evolent Health, Inc. (EVH) Q4 2022 Earnings Call Transcript
Revenue
$382.43M
▲ 54% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Evolent Health, Inc. (EVH) Q3 2022 Earnings Call Transcript
Revenue
$352.58M
▲ 58.5% YoY Diluted EPS
$0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Evolent Health, Inc. (EVH) Q2 2022 Earnings Call Transcript
Revenue
$319.94M
▲ 44.1% YoY Diluted EPS
$-0.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Evolent Health, Inc. (EVH) Q1 2022 Earnings Call Transcript
Revenue
$297.06M
▲ 38.1% YoY Diluted EPS
$-0.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
Evolent Health, Inc. (EVH) Q4 2021 Earnings Call Transcript
Revenue
$248.36M
▲ 0.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Evolent Health, Inc. (EVH) Q3 2021 Earnings Call Transcript
Revenue
$222.47M
▼ 7.1% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Evolent Health, Inc. (EVH) Q2 2021 Earnings Call Transcript
Revenue
$222.06M
▲ 2.2% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Evolent Health, Inc. (EVH) Q1 2021 Earnings Call Transcript
Revenue
$215.07M
▼ 2.8% YoY Diluted EPS
$-0.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Evolent Health, Inc. (EVH) Q4 2020 Earnings Call Transcript
Revenue
$246.54M
▲ 4.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Evolent Health, Inc. (EVH) Q3 2020 Earnings Call Transcript
Revenue
$239.57M
▲ 8.8% YoY Diluted EPS
$-0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-17
Evolent Health, Inc. (EVH) Q2 2020 Earnings Call Transcript
Revenue
$217.30M
▲ 13.2% YoY Diluted EPS
$-2.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Evolent Health, Inc. (EVH) Q1 2020 Earnings Call Transcript
Revenue
$221.23M
▲ 11.9% YoY Diluted EPS
$-0.93
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Evolent Health, Inc. (EVH) Q4 2019 Earnings Call
Revenue
$236.53M
▲ 22.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 webcasts